< Back to companies

inDNA Research Labs is an early stage genomics-driven personalized healthcare startup that is at the forefront of bringing comprehensive genomic analysis to routine clinical care. Our goal is to democratize the use of genomics technologies by empowering physicians to utilize a patient’s genomic profile to improve clinical decisions thus transforming patient care. Our initial focus area is Cancer. We have been awarded BIRAC's Biotechnology Ignition Grant (BIG) to develop a clinical NGS pipeline (called OncoNGx genomic workbench) for detecting and interpreting somatic cancer.

Share
Shareable draft
Get Involved in InDNA

Company Info

Founded
2013
Website
indna.in

Categories

Precision Medicine/Diagnostics

Disease Areas

Technologies

GenomicsGenetic AnalysisPrecision Medicine TechNext-Generation Sequencing
Only accessible to MedStartr community members. Join now

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Sign in to join the conversation.

Sign in to comment
Be the first to comment.

What do you think of InDNA?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in InDNA
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free